Литература
1. Lok A.S., Heathcote
E.J., Hoofnagle J.H. Management of Hepatitis B 2000, Summary of a Workshop.
Gastroenterology 2001;120:1828-53. 2. Gross P.A., Barrett T.L., Dellinger
E.P., Krause P.J., Martone W.J., McGowan J.E., Sweet R.L., et al. Infectious
Diseases Society of America quality standards for infectious diseases: purpose
of quality standards for infectious diseases/ Clin Infect Dis 1994;18:421.
3. Lee W. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45. 4.
McQuillan G.M., Townsend T.R., Fields H.A., Carrol M., Leahy M., Polk B.F.
Seroepidemiology of hepatitis B virus infection in the United States. Am J Med
1989;87(suppl 3A):5S-10S. 5. CDC. Hepatitis B virus: a comprehensive
strategy for limiting transmission in the United States through universal
childhood vaccination. Recommendations of the Immunization Practices Advisory
Committee (ACIP). MMWR 1991;40:RR-13:1-25. 6. Beasley R.P. Hepatitis B
virus: the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
7. McMahon B.J. Hepatocellular carcinoma and viral hepatitis. In: Wilson
R.A., ed. Viral Hepatitis. New York: Marcel Dekker 1997;315-330. 8. Seeger
C., Mason W.S. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:51-68.
9. Ganem D., Schneider R.J. Hepadnaviridae and their replication. In: Knipe
D.M., Howlev P.M., Chanock R.M., Monath T.P., Roizman B., Straus S.E., eds.
Fields Virology. 4th ed. Philadelphia: Lippincott-Raven, 2001:2703-37. 10.
Scaglioni P.P., Melegari M., Wands J.R. Biologic properties of hepatitis B viral
genomes with mutations in the precore promoter and precore open reading frame.
Virology 1997;233:374-81. 11. Buckwold V.E., Xu Z., Chen M., Yen T.S., Ou
J.H. Effects of a naturally occurring mutation in the hepatitis B virus basal
core promoter on precore gene expression and viral replication. J Virol
1996;70:5845-51. 12. Locarnini S., Birch C. Antiviral chemotherapy for
chronic hepatitis B infection: lessons learned from treating HIV-infected
patients. J Hepatol 1999;30:536-50. 13. Maynard J.E. Hepatitis B: global
importance and need for control. Vaccine 1990;8(Suppl):S18-S20. 14. Mast
E.E., Alter M.J., Margolis H.S. Strategies to prevent and control hepatitis B
and C virus infections: a global perspective. Vaccine 1999;17:1730-33. 15.
Margolis H.S., Alter M.J., Hadler S.C. Hepatitis B: evolving epidemiology and
implications for control. Semin Liver Dis 1991;11:84-92. 16. CDC.
Recommendations for protection against viral hepatitis. Recommendations of the
Immunization Practices Advisory Committee (ACIP). MMWR 1985;34:313-35. 17.
CDC. Prevention of perinatal transmission of hepatitis B virus: prenatal
screening of all pregnant women for hepatitis B surface antigen. Recommendations
of the Immunization Practices Advisory Committee (ACIP). MMWR 1988;37:341-6.
18. Scharschmidt B.F., Held M.J., Hollander H.H., Read A.E., Lavine J.E.,
Veereman G., McGuire R.F., et al. Hepatitis B in patients with HIV infection:
relationship lo AIDS and patient survival. Ann Intern Med 1992;117:837-8.
19. Rodriguez-Mendez M.L., Gonzalez-Quintela A., Aguilera A, Barrio E.
Prevalence, patterns and course of past hepatitis B virus infection in
intravenous drug users with HIV-1 infection. Am J Gastroenterol 2000;95:1316-22.
20. Bond W.W., Favero M.S., Petersen N.J., Gravelle C.R., Eben J.W., Maynard
J.E. Survival of hepatitis B virus after drying and storage for one week
[letter]. Lancet 1981;1:550-1. 21. Petersen N.J., Barrett D.H., Bond W.W.,
Berquist K.R., Favero M.S., Bender T.R., Maynard J.E. Hepatitis B surface
antigen in saliva, impetiginous lesions, and the environment in two remote
Alaskan villages. Applied Environ Microbiol 1976:32:572-4. 22. Beasley R.P.,
Hwang L.Y., Lee G.C.Y., Lin C.C., Roan C.H., Huang F.Y., Chen C.L. Prevention of
perinatally transmitted hepatitis B virus infections with hepatitis B immune
globulin and hepatitis B vaccine. Lancet 1983;1:1099-1102. 23. Beasley R.P.,
Hwang L.Y., Lin C.C., Leu M.L., Stevens C.E., Szmuness W., Chen K.P. Incidence
of hepatitis B virus in preschool children in Taiwan. J Infect Dis
1982;146:198-204. 24. Corsaget P., Yvonnet B., Chotard J., Vincelot P., Sarr
M., Diouf C., Chiron J.P., et al. Age- and sex-related study of hepatitis B
virus chronic carrier state in infants from an endemic area (Senegal). J Med
Virol 1987;22:1-5. 25. McMahon B.J., Alward W.L.M., Hall D.B., Heyward W.L.,
Bender T.R., Francis D.P., Maynard J.E. Acute hepatitis B virus infection:
Relation of age to the clinical expression of disease and subsequent development
of the carrier state. J Infect Dis 1985;151:599-603. 26. Tassopoulos N.C.,
Papaevangelou G.J., Sjogren M.H., Roumeliotou-Karayannis A., Gerin J.L., Purcell
R.H. Natural history of acute hepatitis B surface antigen-positive hepatitis in
Greek adults. Gastroenterology 1987;92:1844-50. 27. Horvath J., Raffanti
S.P. Clinical aspects of the interactions between human immunodeficiency virus
and the hepatotropic viruses. Clin Infect Dis 1994;18:339-47. 28. Bodsworth
N., Donovan B., Nightingale B.N. The effect of concurrent human immunodeficiency
virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect
Dis 1989;160:577-82. 29. Hoofnagle J.H., Dusheiko G.M., Seeff L.B., Jones
E.A., Waggoner J.G., Bales Z.B. Seroconversion from hepatitis B e antigen to
antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744-8. 30.
Viola L.A., Harrison I.G., Coleman J.C., Paradinal F.J., Fluker J.L., Evans
B.A., Murray-Lyon I.M. Natural history of liver disease in chronic hepatitis B
surface antigen carriers: survey of 100 patients from Great Britain. Lancet
1981;2:1156-9. 31. Liaw Y.F., Chu C.M., Su I.J., Huang M.J., Lin D.Y.,
Chang-Chien C.S. Clinical and histological events preceding hepatitis B e
antigen seroconversion in chronic type B hepatitis. Gastroenterology
1983;84:216-9. 32. Fattovich G., Rugge M., Brollo L., Pontisso P., Noventa
F., Guido M., Alberti A., et al. Clinical, virologic and histologic outcome
following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
Hepatology 1986;6:167-72. 33. Lok A.S.F., Lai C.L., Wu P.C., Leung E.K.Y.,
Lam T.S. Spontaneous hepatitis e antigen to antibody seroconversion and
reversion in Chinese patients with chronic hepatitis B virus infection.
Gastroenterology 1987;92:1839-43. 34. Lok A.S., Lai C.L. A longitudinal
follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children.
Hepatology 1988,8:1130-3. 35. Chang M.H., Hsu H.Y., Hsu H.C., Ni Y.H., Chen
J.S., Chen D.S. The significance of spontaneous hepatitis e antigen
seroconversion in childhood: with special emphasis on the clearance of hepatitis
e antigen before 3 years of age. Hepatology 1995;22:1387-92. 36. Lee P.I.,
Chang M.H., Lee C.Y., Hsu H.Y., Chen J.S., Chen P.J., Chen D.S. Changes in serum
hepatitis B DNA and aminotransferase levels during the course of chronic
hepatitis B virus infection in children. Hepatology 1990;12:657-60. 37. Lok
A.S.K., Lai C.L. Acute exacerbations in Chinese patients with chronic hepatitis
B (HBV) virus infection: Incidence, predisposing factors and etiology. J Hepatol
1990;10:29-34. 38. Dusheiko G.M., Brink B.A., Conradie J.D., Marimuthu T.,
Sher R. Regional prevalence of hepatitis B, Delta, and human immunodeficiency
virus infection in Southern Africa: a large population survey. Am J Epidemiol
1989;129:138-45. 39. Bortolotti F., Cadrobbi P., Crivellaro C., Guido M.,
Rugge M., Noventa F., Calzia R., et al. Long-term outcome of chronic type B
hepatitis in patients who acquire hepatitis B infection in childhood.
Gastroenterology 1990;99:805-10, 40. Moreno M.R., Otero M., Millan A.,
Castillo I., Cabrerizo M., Jimenez F.J., Oliva H., et al. Clinical and
histological outcome after hepatitis B e antigen to antibody seroconversion in
children with chronic hepatitis B. Hepatology 1999;29:572-5. 41. Stroffolini
T., Mele A., Tosti M.E., Gallo G., Balocchini E., Ragni P., Santonastasi F., et
al. The impact of hepatitis B mass immunisation campaign on the incidence and
risk factors of acute hepatitis B in Italy. J Hepatol 2000;33:980-5. 42. de
Franchis R., Meucci G., Vecchi M., Tatarella M., Colombo M., Del Ninno E., Rumi
N.G., et al. The natural history of asymptomatic hepatitis B surface antigen
carriers. Ann Intern Med 1993;118:191-4. 43. McMahon B.J., Hoick P., Bulkow
L., Snowball M.M. Serologic and clinical outcomes of 1536 Alaska Natives
chronically infected with hepatitis B virus. Ann Int Med 2001;.135:759-68.
44. Colin J.F., Cazals-Hatem D., Loriot M.A., Martinot-Peignoux M, Pham
B.N., Auperin A., Degott C., et al. Influence of human immunodeficiency virus
infection on chronic hepatitis B in homosexual men. Hepatology 1999;29:1306-10.
45. Dragosics B., Ferenci P., Hitchman E., Denk H. Long-term follow-up study
of symptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and
histologic evaluation of 242 cases. Hepatology 1987;7:302-6. 46. Davis G.L.,
Hoofnagle J.H., Waggoner J.G. Spontaneous reactivation of chronic hepatitis B
virus infection. Gastroenterology 1984;86:230-5. 47. Liaw Y.F., Tai D.I.,
Chu C.M., Pao C.C., Chen T.J. Acute exacerbation in chronic type B hepatitis:
comparison between HBeAg and antibody-positive patients. Hepatology 1987;7:20-3.
48. Fattovich G., Brollo L., Alberti A., Pontisso P., Giustina G., Realdi G.
Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology
1988;8:1651-4. 49. Chan H.L.Y., Leung N.W.Y., Hussain M., Wong M.L., Lok
A.S.F. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
Hepatology 2000;31:763-8. 50. Brunetto M.R., Oliveri F., Rocca G., Criscuolo
D., Chiaberge E., Capalbo M., David E., et al. Natural course and response to
interteron of chronic hepatitis B accompanied by antibody to hepatitis B e
antigen. Hepatology 1989;10:198-202. 51. Lindh M., Andersson A.S., Gusdal A.
Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus -
large-scale analysis using a new genotyping method. J Infect Dis
1997;175:1285-93. 52. Laras A., Koskinas J., Avgidis K., Hadziyannis S.J.
Incidence and clinical significance of hepatitis B virus precore gene
translation initiation mutations in e antigen-negative patients. J Viral
Hepatitis 1998;5:241-8. 53. Naoumov N.V., Schneider R., Grotzinger T., Jung
M.C., Miska S., Pape G.R., Will H. Precore mutant hepatitis B virus infection
and liver disease. Gastroenterology 1992:102:538-43. 54. Rodriguez-Frias F.,
Buti M., Jardi R., Cotrina M., Viladomiu L., Esteban R., Guardia J. Hepatitis B
virus infection: precore mutants and its relation to viral genotypes and core
mutations. Hepatology 1995;22:1641-7. . 55. Tu H., Xiong S.D., Trepo C., Wen
Y.M. Frequency of hepatitis B virus e-minus mutants varies among patients from
different areas of China. J Med Virol 1997;51:85-9. 56. Shindo M., Hamada
K., Koya S., Sokawa Y., Okuno T. The clinical significance of core promoter and
precore mutations during the natural course and interferon therapy in patients
with chronic hepatitis B Am J Gastroenterol 1999;94:237-45. 57. Zarski J.P.,
Marcellin P., Cohard M., Lutz J.M., Bouche C., Rais A. Comparison of
anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. French
Multicentre Group. J Hepatol 1994;20;636-40. 58. Gray A.H., Fang J.W., Davis
G.L., Mizokami M., Wu P.C., Williams R., Schuster S.M., et al. Variations of
hepatitis B virus core gene sequence in Western patients with chronic hepatitis
B virus infection. J Viral Hepatitis 1997;4:371-8. 59. Grandjacques C.,
Pradat P., Stuyver L., Chevallier M., Chevallier P., Pichoud C., Maisonnas M.,
et al. Rapid detection of genotypes and mutations in the pre-core promoter and
the pre-core region of hepatitis B virus genome: correlation with viral
persistence and disease severity. J Hepatol 2000;33:430-9. 60. Hadziyannis
S. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition
to pathogenesis and treatment. Viral Hepatitis Rev 1995;1:7-36. 61. Di Marco
V., Camma C., Vaccaro A., Giunta M., Martorana G., Fuschi P., Almasio P., et al.
The long-term course of chronic hepatitis B. Hepatology 1999;30:257-64. 62.
Brunetto M.R, Giarin M.M., Oliveri F., Chiaberge E., Baldi M., Alfarano A.,
Serra A., et al. Wild-type and e antigen-minus hepatitis B viruses and course of
chronic hepatitis. Proc Natl Acad Sci U S A 1991;88:4186-90. 63. Chu C.M.,
Yeh C.T., Chiu C.T., Sheen I.S., Liaw Y.F. Precore mutant of hepatitis B virus
prevails in acute and chronic infections in an area in which hepatitis B is
endemic. J Clin Microbiol 1996;34:1815-8. 64. Kramvis A., Kew M.C., Bukofzer
S. Hepatitis B virus precore mutants in serum and liver of Southern African
blacks with hepatocellular carcinoma. J Hepatol 1998;28:132-41. 65. Lok
A.S., Akarca U., Greene S. Mutations in the pre-core region of hepatitis B virus
serve to enhance the stability of the secondary structure of the pre-genome
encapsidation signal. Proc Natl Acad Sci USA 1994;91:4077-81. 66. Carman
W.F., Jacyna M.R., Hadziyannis S., Karayiannis P., McGarvey M.J., Makris A.,
Thomas H.C. Mutation preventing formation of hepatitis B e antigen in patients
with chronic hepatitis B infection. Lancet 1989;2:588-91. 67. Okamoto H.,
Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., et al.
Hepatitis B virus with mutations in the core promoter for an e antigen-negative
phenotype in carriers with antibody to e antigen. J Virol 1994;68:8102-10.
68. Magnius L.O., Norder H. Subtypes, genotypes and molecular epidemiology
of the hepatitis B virus as reflected by sequence variability of the S-gene.
Intervirology 1995;38:24-34. 69. Adachi J., Kaneko S., Matsushita E.,
Inagaki Y., Unoura M., Kobayashi K. Clearance of HBsAg in seven patients with
chronic hepatitis. Hepatology 1992;16:1334-7. 70. LiawY.F., Sheen I.S., Chen
T.J., Chu C.M., Pao C.C. Incidence, determinants and significance of delayed
clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective
study. Hepatology 1991;13:627-31. 71. Gandhi M.J., Yang G.G., McMahon B.,
Vyas G. Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal
occult viremia in surface antigen negative/antibody-positive carriers by
polymerase chain reaction. Transfusion 2000:40:910-6. 72. Yu M.W., Hsu F.C.,
Sheen I.S., Chu C.M., Lin D.Y., Chen C.J., Liaw Y.F. Prospective study of
hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B
virus carriers. Am J Epidemiol 1997;145:1039-47.
|